Affinity Asset Advisors »

Altimmune shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Altimmune (ALT) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Altimmune

Tip: Access up to 7 years of quarterly data

All positions including Altimmune held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Altimmune by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $774k 200k 3.87

More positions owned by Affinity Asset Advisors

Insmed Com Par $.01 (INSM)
Verona Pharma Sponsored Ads (VRNA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Xenon Pharmaceuticals (XENE)
Madrigal Pharmaceuticals (MDGL)
Apogee Therapeutics (APGE)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)
Abivax Sa Sponsored Ads (ABVX)
Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Merus N V (MRUS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Lexeo Therapeutics (LXEO)

View all positions for Affinity Asset Advisors

Top funds holding Altimmune

Vanguard Group
BlackRock
Susquehanna International
State Street Corporation
Tang Capital Management
Citadel Advisors
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Knoll Capital Management
Ikarian Capital
UBS Group
Morgan Stanley
Northern Trust
Squarepoint Ops

View all funds holding Altimmune